Veradigm (NASDAQ:MDRX – Free Report) had its price target raised by Stephens from $7.00 to $13.00 in a report published on Friday morning,Benzinga reports. Stephens currently has an equal weight rating on the software maker’s stock.
Separately, StockNews.com started coverage on Veradigm in a research report on Tuesday, January 28th. They issued a “hold” rating on the stock.
View Our Latest Research Report on MDRX
Veradigm Stock Down 31.8 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- Using the MarketBeat Dividend Yield Calculator
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- Basic Materials Stocks Investing
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
